SAN FRANCISCO (GenomeWeb News) – The JP Morgan Healthcare Conference wrapped up today with a handful of life science tools and molecular diagnostics companies presenting to investors.

Affymetrix

Earlier this week Affymetrix announced a restructuring aimed at returning the firm to profitability and revenue growth. That restructuring included an 8 percent workforce reduction, or 100 employees.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.